March 11, 2019
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Jessica R. Berman, MD
John A. Carrino, MD, MPH
Jackie Finik
Kyriakos A. Kirou, MD, DSc, FACP
Sarah Lieber, MD
Stephen A. Paget, MD
Lisa R. Sammaritano, MD
Dina Sheira
Number of patients: 70
Enrollment period: Ongoing; anticipated completion 6/30/19
Duration of follow-up: 1 year
Inclusion criteria:
Exclusion criteria:
Sarah Lieber, MD
liebers@hss.edu
212.774.2482